Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVNC Revance Therapeutics Inc

交易中 07-17 11:21:21 EDT

4.09

-0.16

-3.88%

最高4.38	最低4.05	成交量105.10万
今开4.08	昨收4.25	日振幅7.72%
总市值4.27亿	流通市值3.42亿	总股本1.04亿
成交额438.34万	换手率1.26%	流通股本8,366万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVNC","market":"US","secType":"STK","nameCN":"Revance Therapeutics Inc","latestPrice":4.085,"timestamp":1721229680558,"preClose":4.25,"halted":0,"volume":1050973,"delay":0,"floatShares":83656774,"shares":104448502,"eps":-3.635631,"marketStatus":"交易中","marketStatusCode":2,"change":-0.165,"latestTime":"07-17 11:21:21 EDT","open":4.08,"high":4.378,"low":4.05,"amount":4383434.4469685,"amplitude":0.077176,"askPrice":4.09,"askSize":1300,"bidPrice":4.08,"bidSize":1211,"shortable":3,"etf":0,"ttmEps":-3.635631,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721246400000},"adr":0,"listingDate":1391662800000,"adjPreClose":4.25,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.05,"preClose":4.25,"latestTime":"09:26 EDT","volume":13736,"amount":58418.31516,"timestamp":1721222790469},"postHourTrading":{"tag":"盘后","latestPrice":4.3,"preClose":4.25,"latestTime":"19:56 EDT","volume":44080,"amount":187630.6923,"timestamp":1721174178625},"volumeRatio":1.625022,"impliedVol":1.4331,"impliedVolPercentile":0.7937},"requestUrl":"/m/hq/s/RVNC/wiki","defaultTab":"wiki","newsList":[{"id":"2451130119","title":"Revance Therapeutics, Inc.盘中异动 快速上涨5.12%报4.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451130119","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451130119?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:23","pubTimestamp":1721139837,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时23分，Revance Therapeutics, Inc.股票出现波动，股价急速拉升5.12%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1921.15%、1133.98%、141.93%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为55.14%、47.63%、44.12%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716222358941f775b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716222358941f775b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RVNC","LU0053671581.USD","BK4585","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2450306536","title":"Revance Therapeutics, Inc.盘中异动 早盘股价大涨5.35%报3.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450306536","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450306536?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:39","pubTimestamp":1720791563,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时39分，Revance Therapeutics, Inc.股票出现异动，股价急速拉升5.35%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为787.44%、81.57%、29.97%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Kazia Therapeutics Limited，振幅分别为55.97%、20.00%、16.53%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213923af921d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213923af921d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","LENZ","LU0053671581.USD","RVNC","BK4585","BK4139"],"gpt_icon":0},{"id":"2450138928","title":"Revance Therapeutics, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450138928","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450138928?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:48","pubTimestamp":1720619322,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时48分，Revance Therapeutics, Inc.股票出现波动，股价大幅拉升5.19%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Kazia Therapeutics Limited涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为1777.80%、867.05%、524.27%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.，振幅分别为119.83%、62.50%、59.23%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710214843aef8fd13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710214843aef8fd13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RVNC","LU0053671581.USD","BK4585","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2448168770","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.06%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448168770","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448168770?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:32","pubTimestamp":1719930723,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日22时32分，Revance Therapeutics, Inc.股票出现波动，股价大幅下跌5.06%。截至发稿，该股报2.44美元/股，成交量20.3699万股，换手率0.20%，振幅5.84%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702223203941f3259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702223203941f3259&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","RVNC","BK4585","LENZ","LU0053671581.USD","BK4588"],"gpt_icon":0},{"id":"2448556916","title":"Revance Therapeutics, Inc.盘中异动 快速拉升5.06%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448556916","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448556916?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:00","pubTimestamp":1719842416,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时00分，Revance Therapeutics, Inc.股票出现波动，股价大幅上涨5.06%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Senti Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Senti Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.、Geovax Labs, Inc.较为活跃，换手率分别为234.02%、86.04%、75.80%，振幅较大的相关个股有Senti Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为68.88%、28.78%、28.45%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220016941f2c0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220016941f2c0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","LENZ","LU0053671581.USD","RVNC","BK4585","BK4139"],"gpt_icon":0},{"id":"2446551767","title":"Revance Therapeutics, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446551767","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446551767?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:59","pubTimestamp":1719500348,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时59分，Revance Therapeutics, Inc.股票出现异动，股价快速拉升5.34%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1945.30%、307.25%、257.67%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为294.39%、127.05%、81.43%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627225908941f1d7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627225908941f1d7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LENZ","BK4139","BK4585","LU0053671581.USD","RVNC","BK4007"],"gpt_icon":0},{"id":"2446687872","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446687872","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446687872?lang=zh_cn&edition=full","pubTime":"2024-06-26 02:46","pubTimestamp":1719341201,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日02时46分，Revance Therapeutics, Inc.股票出现异动，股价急速下挫5.06%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.69%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为1121.61%、237.67%、180.28%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.，振幅分别为272.73%、77.13%、47.00%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626024642af8f2450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626024642af8f2450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVNC","BK4139","BK4588","LENZ","LU0053671581.USD","BK4585","BK4007"],"gpt_icon":0},{"id":"2445473799","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445473799","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445473799?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:25","pubTimestamp":1718997929,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时25分，Revance Therapeutics, Inc.股票出现异动，股价大幅跳水5.05%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622032529941f02c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622032529941f02c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","RVNC","BK4139","LU0053671581.USD","LENZ","BK4585"],"gpt_icon":0},{"id":"2443603416","title":"Revance Therapeutics, Inc.盘中异动 大幅下挫5.05%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443603416","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443603416?lang=zh_cn&edition=full","pubTime":"2024-06-15 01:20","pubTimestamp":1718385640,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日01时20分，Revance Therapeutics, Inc.股票出现异动，股价快速跳水5.05%。截至发稿，该股报2.82美元/股，成交量51.7398万股，换手率0.50%，振幅5.72%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615012040968145bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615012040968145bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4007","LENZ","BK4588","RVNC","BK4139","BK4585"],"gpt_icon":0},{"id":"2442855268","title":"Revance Therapeutics, Inc.盘中异动 急速上涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442855268","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442855268?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199103,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Revance Therapeutics, Inc.股票出现异动，股价急速拉升7.14%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Avidity Biosciences, Inc.、Molecular Partners Ag涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为36.75%、18.95%、3.60%，振幅较大的相关个股有Passage Bio, Inc.、Xortx Therapeutics Inc.、Akari Therapeutics Plc，振幅分别为21.10%、20.93%、8.28%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221314395a8e706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221314395a8e706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RVNC","LENZ","LU0053671581.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2440954231","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440954231","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440954231?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:46","pubTimestamp":1717512389,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时46分，Revance Therapeutics, Inc.股票出现异动，股价快速跳水5.32%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Annexon, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Bio-Path Holdings, Inc.、Fresh2 Group Limited、Annexon, Inc.较为活跃，换手率分别为62.01%、39.04%、36.65%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Annexon, Inc.、Silo Pharma, Inc.，振幅分别为181.00%、35.37%、28.08%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604224629941ec48c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604224629941ec48c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","RVNC","LU0053671581.USD","BK4585","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2439508883","title":"Revance Therapeutics, Inc.盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439508883","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439508883?lang=zh_cn&edition=full","pubTime":"2024-05-30 00:43","pubTimestamp":1717001003,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日00时43分，Revance Therapeutics, Inc.股票出现波动，股价急速上涨5.06%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、依特钠、Onconetix, Inc.涨幅较大，Mustang Bio, Inc.、Scorpius Holdings, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为510.02%、105.81%、34.98%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Nkgen Biotech Inc C/Wts 31/05/2028、Mustang Bio, Inc.，振幅分别为115.00%、50.40%、50.08%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530004323968108e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530004323968108e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4007","LENZ","RVNC","LU0053671581.USD","BK4585"],"gpt_icon":0},{"id":"2436358181","title":"Revance Therapeutics, Inc.2024财年第一财季实现净利润-49.53百万美元，同比增加17.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436358181","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436358181?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:18","pubTimestamp":1716049087,"startTime":"0","endTime":"0","summary":"3月31日，Revance Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-49.53百万美元，同比增加17.16%；其中营业收入为51.94百万美元，同比增加5.29%，每股基本收益为-0.58美元。从资产负债表来看，Revance Therapeutics, Inc.总负债6.07亿美元，其中短期债务12.13百万美元，资产负债比为0.84，流动比率为0.06。机构评级：截至2024年3月31日，当前有11家机构对Revance Therapeutics, Inc.目标价做出预测，其中目标均价为12.82美元，其中最低目标价为6.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190018198b15ecb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190018198b15ecb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVNC","LENZ"],"gpt_icon":0},{"id":"2435519352","title":"Revance Therapeutics, Inc.盘中异动 早盘快速上涨6.02%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519352","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435519352?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:30","pubTimestamp":1715693452,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时30分，Revance Therapeutics, Inc.股票出现异动，股价大幅上涨6.02%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。消息层面，截至21时30分，Revance Therapeutics, Inc.股票正面舆情新闻比例16.67%。该信息摘要如下：HC Wainwright & Co.：维持Revance Therapeutics评级，由买入调整至买入评级, 目标价由12.00美元调整至11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421305287e87cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421305287e87cab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","RVNC","BK4588","LU0053671581.USD","BK4585"],"gpt_icon":0},{"id":"2435230387","title":"HC Wainwright & Co.：维持Revance Therapeutics(RVNC.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435230387","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435230387?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:45","pubTimestamp":1715618702,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Revance Therapeutics(RVNC.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140045038b028965&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140045038b028965&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RVNC"],"gpt_icon":0},{"id":"2435337386","title":"Revance Therapeutics, Inc.盘中异动 早盘快速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435337386","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435337386?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:36","pubTimestamp":1715607362,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时36分，Revance Therapeutics, Inc.股票出现波动，股价急速拉升5.12%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。消息层面，截至21时36分，Revance Therapeutics, Inc.股票正面舆情新闻比例16.67%。该信息摘要如下：瑞穗银行：维持Revance Therapeutics评级，由中性调整至中性评级, 目标价由9.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132136027a599ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132136027a599ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","LU0053671581.USD","LENZ","BK4139","BK4007","RVNC"],"gpt_icon":0},{"id":"2434515588","title":"Revance Therapeutics, Inc.盘中异动 股价大跌9.32%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434515588","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434515588?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:31","pubTimestamp":1715347871,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时31分，Revance Therapeutics, Inc.股票出现异动，股价急速下跌9.32%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。该信息摘要如下：瑞穗银行：维持Revance Therapeutics评级，由中性调整至中性评级, 目标价由9.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102131118750f5c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102131118750f5c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","LU0053671581.USD","BK4139","BK4588","LENZ","RVNC"],"gpt_icon":0},{"id":"2434853631","title":"瑞穗银行：维持Revance Therapeutics(RVNC.US)评级，由中性调整至中性评级, 目标价由9.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434853631","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434853631?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:15","pubTimestamp":1715343327,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Revance Therapeutics(RVNC.US)评级，由中性调整至中性评级, 目标价由9.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102015298750bc79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102015298750bc79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVNC","LENZ"],"gpt_icon":0},{"id":"2434023617","title":"Revance Therapeutics Inc 报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434023617","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434023617?lang=zh_cn&edition=full","pubTime":"2024-05-10 05:01","pubTimestamp":1715288502,"startTime":"0","endTime":"0","summary":"   * Revance Therapeutics Inc   报告，截至3月底的季度调整后每股亏损58美分，高于去年同期的每股-74美分。十位分析师对该季度的平均预期是每股亏损 75 美分。华尔街预期为每股亏损 1.19 美元至-50 美分。* 营收同比增长 110.6%，达到 1.0387 亿美元；分析师预期为 5663 万美元。* Revance Therapeutics 公司公布的本季度每股收益为亏损 58 美分。* 该公司的季度亏损额为 5315 万美元。* Revance Therapeutics Inc 本季度股价下跌了 13.2%，今年迄今为止亏损了 51.4%。* 华尔街对 Revance Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","RVNC","LENZ","LU0053671581.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2433875785","title":"Revance Therapeutics Inc    预计每股亏损 75 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433875785","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433875785?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:07","pubTimestamp":1715126843,"startTime":"0","endTime":"0","summary":"   * Revance Therapeutics Inc    将于5月9日发布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将有所增长。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于田纳西州纳什维尔的公司的营收有望从去年同期的4933万美元增长14.8%，达到5663.4万美元。* LSEG 分析师对 Revance Therapeutics Inc 的平均预期是每股亏损 75 美分。* 华尔街对 Revance Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元，高于其上次收盘价 4.38 美元。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVNC","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revance.com","stockEarnings":[{"period":"1week","weight":0.4706},{"period":"1month","weight":0.5071},{"period":"3month","weight":0.1303},{"period":"6month","weight":-0.2672},{"period":"1year","weight":-0.8092},{"period":"ytd","weight":-0.5165}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revance Therapeutics, Inc.于1999年8月10日成立于特拉华公司，当时名为Essentia Biosystems公司。公司是一家处于专业临床阶段的生物制药公司，专注于开发、制造和商业化用以美容和治疗的异常型肉毒杆菌毒素产品。肉毒杆菌毒素是一种良好的蛋白，目前广泛应用于美容和治疗适应症，在美国和其他国家是一个数十亿美元的市场。目前批准和商用的肉毒杆菌毒素都是注入型的。RT001, 公司的主要候选产品，是a型肉毒毒素局部配方,相对于现有注射肉毒杆菌毒素市场产品，被认为有显著的优势。公司的第二个候选产品RT002，是一种新型注射肉毒杆菌毒素类型的配方，其设计更有针对性，与其他肉毒杆菌毒素注射产品相比，更持久。这些候选产品，结合了公司的净化肉毒杆菌毒素和专有肽输送系统。公司对其两个候选产品，在全球拥有发行权利。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.017146},{"month":2,"riseRate":0.6,"avgChangeRate":0.034292},{"month":3,"riseRate":0.363636,"avgChangeRate":0.011213},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.023839},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.009304},{"month":6,"riseRate":0.636364,"avgChangeRate":0.025437},{"month":7,"riseRate":0.272727,"avgChangeRate":0.036049},{"month":8,"riseRate":0.4,"avgChangeRate":-0.015335},{"month":9,"riseRate":0.5,"avgChangeRate":0.012838},{"month":10,"riseRate":0.4,"avgChangeRate":-0.075574},{"month":11,"riseRate":0.3,"avgChangeRate":-0.003095},{"month":12,"riseRate":0.6,"avgChangeRate":0.084189}],"exchange":"NASDAQ","name":"Revance Therapeutics Inc","nameEN":"Revance Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revance Therapeutics Inc,RVNC,Revance Therapeutics Inc股票,Revance Therapeutics Inc股票老虎,Revance Therapeutics Inc股票老虎国际,Revance Therapeutics Inc行情,Revance Therapeutics Inc股票行情,Revance Therapeutics Inc股价,Revance Therapeutics Inc股市,Revance Therapeutics Inc股票价格,Revance Therapeutics Inc股票交易,Revance Therapeutics Inc股票购买,Revance Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况